American Cancer Society Institutional Research Grant
The purpose of the American Cancer Society’s Institutional Research Grant (ACS-IRG) is to support the initiation of promising new cancer-related research projects by junior faculty members (Assistant Professors or their equivalents), so they can obtain preliminary results that will enable them to compete successfully for national research grants. IRGs are intended to support independent, self-directed investigators early in their careers, for whom the institution must provide research facilities or space customary for an independent investigator.
Applicants for the individual awards should be within six years of their first independent research or faculty appointment. This funding mechanism is not to provide supplemental research support but it can be used as bridge funding for faculty members who have been PI on research grant(s) from major national funding agencies.
Cancer-related research includes but is not restricted to genetic mechanisms of cancer, molecular mechanisms of cancer progression and metastasis, development of novel cancer therapeutic models and translational research, transplantation, cancer immunology, and immunotherapies.
Grant Program Contacts
Application process, requirements, eligibility:
Katie Thomas
Research Development Coordinator
612-624-8679
[email protected]
Applicability of research:
Kaylee Schwertfeger, PhD
[email protected]
Grantees
Armin Rashidi, MD, PhD, Department of Medicine, Medical School
Beshay Zordoky, MSc, PhD, Experimental and Clinical Pharmacology, College of Pharmacy
Joseph Topczewski. PhD
2016
The Lyna Signaling Pathway in Tumor-Associated Macrophages
Tanya Freedman, PhD, Department of Pharmacology, Medical School
Risk Factors of 'Chemo Brain' among Women Treated for Ovarian Cancer
Rachel Vogel, PhD, Department of Obstetrics, Gynecology and Women’s Health, Medical School
Assessing the effect of Glucobrassicin-rich Brussels Sprouts on the Metabolism of Deuterated Phenanthrene in Current and Former Cigarette Smokers
Naomi Fujioka, MD, Department of Medicine, Medical School
A Microbiome-based Diagnostic for Colorectal Cancer
Ran Blekhman, PhD, Department of Genetics, Cell Biology and Development, Medical School
2017
2014
PELP1 Protein Interactions that Promote Early Mammary Carcinogenesis
Julie Ostrander, PhD, Department of Medicine, Medical School
Understanding the Effects of Prostate Cancer on Caregivers for Gay and Bisexual Men
Benjamin D. Capistrant, ScD, Division of Epidemiology & Community Health, School of Public Health
Defining the Role of MICA in Pancreatic Cancer
Anna Prizment, PhD, Division of Epidemiology & Community Health, School of Public Health
The Role of the Immune System in Development of Cardiometabolic Syndrome among Survivors of Hematopoietic Cell Transplantation
Lucie Turcotte, MD, MPH, Department of Pediatrics, Medical School
2015
AMACR Promoter Driven Reporter Genes for Prostate Cancer Imaging
Aaron M. LeBeau, PhD, Department of Pharmacology, Medical School
Decoding the Cellular Mechano-some at a Molecular Level using Novel Fluorescent Molecular Tension Sensors
Wendy Gordon, PhD, Department of Biochemistry, Molecular Biology and Biophysics, Medical School
DNA Adductomics for the Investigation of Alcohol Related DNA-damage
Silvia Balbo, PhD, Division of Environmental Health Sciences, School of Public Health
Cell Cycle Control in Latent Breast Preneoplastic Cells
Cheuk T. Leung, PhD, Department of Pharmacology, Medical School
2012
Role of Tumor Suppressor CHD5 in DNA Damage Repair
Anindya Bagchi, PhD, Genetics, Cell Biology and Development, Medical School
Tunneling Nanotubes as a Mechanism for Intercellular Transfer of microRNAs and Cellular Contents in Colon Cancer
Emil Lou, MD, PhD, Department of Medicine, Medical School
Translational Regulation of p53 Induction in Response to Cellular Stress
Da-Qing Yang, PhD, Section of Nutrition and Metabolism, Hormel Institute
Targeting PTEN/AKT to Downregulate P-gp and BCRP for Improved Glioblastoma Therapy
Bjoern Bauer, PhD, Department of Pharmacy Practice and Pharmaceutical Sciences, College of Pharmacy
Phase II Pilot Study to Assess LMI Vaccine with Ipilimumab
Gautam Jha, MBBS, MS, Department of Medicine, Medical School
Development of Novel p16INK4a Mimetics as Anticancer Therapy
Mark Klein, MD, Department of Medicine, Medical School
2013
RAS Signaling Pathways in the Maintenance of Acute Myeloid Leukemia Stem Cells
Zohar Sachs, PhD, Department of Medicine, Medical School
The Dual Role of microRNA-206 in Preventing Both Non-alcoholic Fatty Liver Disease and the Development of Hepatocellular Carcinoma
Guisheng Song, PhD, Department of Medicine, Medical School
Towards Global Characterization of Proline Hydroxylome in Response to Hypoxia
Yue Chen, PhD, Biochemistry, Molecular Biology, and Biophysics, Medical School
PELP1 Protein Interactions that Promote Early Mammary Carcinogenesis
Julie Ostrander, PhD, Department of Medicine, Medical School
Polarity Switching Peptides for CREB:KIX Inhibition
William Pomerantz, PhD, Department of Chemistry, College of Science and Engineering